Tumor lysis syndrome signal with the combination of encorafenib and binimetinib for malignant melanoma: a pharmacovigilance study using data from the FAERS database

• Main Authors: Shuang Xia (Author), Jing-Wen Xu (Author), Kang-Xin Yan (Author), Yoshihiro Noguchi (Author), Mayur Sarangdhar (Author), Miao Yan (Author)
• 格式: 图书
• 出版: Frontiers Media S.A., 2024-09-01T00:00:00Z.
• 主题: article
• 在线阅读: Connect to this object online.

ObjectiveTo investigate the potential association between tumor lysis syndrome (TLS) and drugs for the treatment of malignant melanoma (MM).MethodsReports of TLS recorded in the FDA Adverse Event Reporting System (FAERS) (January 2004-2023q3) were identified. Demographic and clinical characteristics...